Project Details
Description
Safety Study of Vemuafenib, an Oral Inhibitor of BRAFV600E in Children with Recurrent/Refractory BRAFV600E-mutant astrocytomas
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/18 → 12/31/18 |
Funding
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- GENENTECH, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.